Piramal Pharma Ltd.

₹211.9

- 0.60 (-0.28%)

04:01 pm - close price

BSE: PPLPHARMA

NSE: PPLPHARMA

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -2.46Good: 5

❌

Adjusted EPS

Bad: 3Current: -2.46Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 1.24Good: 20

❌

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -4.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 31.28Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -2.46Good: 5

❌

Adjusted EPS

Bad: 3Current: -2.46Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 1.24Good: 20

❌

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -4.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 31.28Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	1911.38	1958.57	2552.36	1951.14
Expenditure+	1645.74	1690.20	2022.43	1746.65
Other Income+	49.19	61.51	26.38	19.54
Operating Profit	265.64	268.37	529.93	204.49
Interest	109.87	105.88	114.22	106.96
Depreciation and Amortization	184.51	186.32	196.13	184.55
Profit Before Tax	39.56	19.36	227.48	-45.08
Tax+	34.54	9.25	126.21	43.56
Net Profit	5.02	10.11	101.27	-88.64

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	6559.10	7081.55	8171.16	9151.18	8869.08
Operational Expenses+	5609.44	6453.31	7000.65	7733.31	7976.59
Operating Profit	949.66	628.24	1170.51	1417.87	892.49
Other Income	275.80	225.11	201.14	161.77	242.43
OPM %	14.48	8.87	14.32	15.49	10.06
Depreciation and Amortisation	586.18	676.69	740.57	816.34	831.24
Interest	198.25	344.18	448.49	421.59	340.80
Profit Before Tax	484.98	-120.15	179.29	414.64	-176.06
Tax	109.02	53.85	166.51	324.42	149.88
Net Profit	375.96	-186.46	17.82	91.13	-325.94

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	12717.19	14436.54	14925.31	15368.75	17566.77
Liabilities+	12717.19	14436.54	14925.31	15368.75	17566.77

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	766.42	483.89	1004.54	892.30	1652.60
Cash from Investing Activity	-1812.10	-1338.78	-434.01	-477.46	-826.03
Cash from Financing Activity	794.19	817.79	-422.36	-440.83	-38.98
Net Cash Flow	-251.49	-37.10	148.17	-25.99	787.59
Opening Cash & Cash Equivalents	261.97	85.18	53.23	219.19	182.32
Closing Cash & Cash Equivalents	85.18	53.23	219.19	182.32	976.26

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	34.80	34.86	34.86	34.86	34.86	34.95	34.95	34.95	34.95	35.02
Public+	65.20	65.14	65.14	65.14	65.14	65.05	65.05	65.05	65.05	64.98
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	461096	450661	453830	462511	458430	432843	418442	359751	306398	297996

Corporate Actions

210 events in the last 3 years

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	1911.38	1958.57	2552.36	1951.14
Expenditure+	1645.74	1690.20	2022.43	1746.65
Other Income+	49.19	61.51	26.38	19.54
Operating Profit	265.64	268.37	529.93	204.49
Interest	109.87	105.88	114.22	106.96
Depreciation and Amortization	184.51	186.32	196.13	184.55
Profit Before Tax	39.56	19.36	227.48	-45.08
Tax+	34.54	9.25	126.21	43.56
Net Profit	5.02	10.11	101.27	-88.64

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	6559.10	7081.55	8171.16	9151.18	8869.08
Operational Expenses+	5609.44	6453.31	7000.65	7733.31	7976.59
Operating Profit	949.66	628.24	1170.51	1417.87	892.49
Other Income	275.80	225.11	201.14	161.77	242.43
OPM %	14.48	8.87	14.32	15.49	10.06
Depreciation and Amortisation	586.18	676.69	740.57	816.34	831.24
Interest	198.25	344.18	448.49	421.59	340.80
Profit Before Tax	484.98	-120.15	179.29	414.64	-176.06
Tax	109.02	53.85	166.51	324.42	149.88
Net Profit	375.96	-186.46	17.82	91.13	-325.94

Ratios

Reported EPS

Bad: 2Current: -2.46Good: 5

❌

Adjusted EPS

Bad: 3Current: -2.46Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 1.24Good: 20

❌

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -4.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 31.28Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -2.46Good: 5

❌

Adjusted EPS

Bad: 3Current: -2.46Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 1.24Good: 20

❌

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -4.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 31.28Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	766.42	483.89	1004.54	892.30	1652.60
Cash from Investing Activity	-1812.10	-1338.78	-434.01	-477.46	-826.03
Cash from Financing Activity	794.19	817.79	-422.36	-440.83	-38.98
Net Cash Flow	-251.49	-37.10	148.17	-25.99	787.59
Opening Cash & Cash Equivalents	261.97	85.18	53.23	219.19	182.32
Closing Cash & Cash Equivalents	85.18	53.23	219.19	182.32	976.26

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	12717.19	14436.54	14925.31	15368.75	17566.77
Liabilities+	12717.19	14436.54	14925.31	15368.75	17566.77

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	34.80	34.86	34.86	34.86	34.86	34.95	34.95	34.95	34.95	35.02
Public+	65.20	65.14	65.14	65.14	65.14	65.05	65.05	65.05	65.05	64.98
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	461096	450661	453830	462511	458430	432843	418442	359751	306398	297996

Piramal Pharma Ltd.

₹211.9

- 0.60 (-0.28%)

04:01 pm - close price

BSE: PPLPHARMA

NSE: PPLPHARMA

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

210 events in the last 3 years